C
Lin Chang, MD
Lin Chang is a gastroenterologist and physician scientist who serves as Co-Director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience, an interdisciplinary center with a research and clinical focus on the interactions of pain, stress and emotions in health and disease. She has served as Co-Director of the Administrative Core of our Center’s NIH Specialized Centers of Research (SCOR), which has been funded for the past 16 years. Our SCOR has focused on sex differences in brain-gut interactions mainly with regard to irritable bowel syndrome (IBS). She has served as PI of one of the projects for each cycle. For this SCORE renewal, she will serve as Multi-PI, Co-Lead of Project 1, Co-Lead of the Career Enhancement Core (CEC), and Co-Lead of the Administrative Core. As Co-Lead of the CEC, she will oversee the collaboration with the pilot and feasibility programs to provide seed grant funding, oversee the recruitment and mentoring of young investigators, and organization of educational conferences. She has been performing clinical and translational research studies, including clinical treatment trials for 25 years. Her research has focused on brain-gut interactions, specifically pathophysiologic mechanisms, clinical symptoms, health outcomes, and treatment in IBS. She has mentored 3 gastroenterology research fellows on the UCLA Gastroenterology T32 training grant in addition to 10 clinical GI fellows, 11 medical residents, 3 post-docs, 8 visiting scientists, 10 medical students, and 5 pre-med students. Her leadership positions include Vice-Chief of the Division of Digestive Diseases at UCLA, Program Director of the UCLA GI Fellowship Program, Clinical Research Councilor of the AGA Governing Board, President of the American Neurogastroenterology and Motility Society (ANMS), member of the Rome Foundation Board of Directors. She currently serving a 4-year term on the NIH Clinical, Integrative and Molecular Gastroenterology Study Section and FDA GI Advisory Committee.
Publications
http://www.ncbi.nlm.nih.gov/sites/myncbi/lin.chang.1/bibliography/40548865/public
10833 Le Conte Avenue Center for Health Sciences 42-210 Los Angeles CA 90095 United States
Marie-Francoise Chesselet, MD, PhD
Marie-Françoise Chesselet is the Charles H. Markham Professor of Neurology, distinguished Professor in the Departments of Neurology and Neurobiology, and Interim Chair of the Department of Neurology at UCLA. After receiving the M.D. and Ph.D. degrees in Paris, France, she held research positions in France and faculty positions at the Medical College of Pennsylvania and the University of Pennsylvania, before joining UCLA in 1996. At UCLA, Dr. Chesselet chaired the Department of Neurobiology from 2002 to 2013 and is currently the Director of the Integrative Center for Neural Repair, which includes the Center for the Study of Parkinson’s Disease at UCLA she created in 1998. She has directed the NINDS-funded UCLA UDALL Center for Parkinson’s disease research from 1998 to 2013, the NIEHS-funded UCLA Center for Gene Environment in Parkinson’s Disease from 2002 to 2014, and the UCLA Advanced Center for Parkinson’s Disease Research of the American Parkinson Disease Association since 1998. Dr. Chesselet has directed graduate programs at the University of Pennsylvania and UCLA and has directed the NINDS-funded Training Program in Neural Repair from 1998 to 2014. Her laboratory conducts research on the molecular mechanisms of disorders of the basal ganglia and new treatments for Parkinson’s and Huntington’s diseases. Her work has been extensively supported by the NIH, the Michael J. Fox Foundation, Cure HD Initiative, and several bio pharmaceutical companies. She currently holds grants from the Department of Defense, CIRM, and Tsumura Inc. Dr. Chesselet is a Fellow of the American Association for the Advancement of Science and currently chair its section on Neuroscience. She just completed a 4 years term on the National Advisory Environmental Health Sciences Council.
UCLA Neuro / Neurobiology BOX 951769, B-114 RNRC Los Angeles CA 90095
Mark Cohen, PhD
Mark Cohen’s training is equal parts engineering and neuroscience. His contributions include his critical role in the development of practical echo-planar scanning, ultra-fast MRI applications, contrast-based and BOLD functional MRI, applications of linear systems analysis to increase fMRI sensitiivity and resolution, and concurrent recordings of EEG and fMRI to better understand brain dynamics and distributed processing. He and his lab have contributed to an understanding of the power of pattern recognition and machine learning to both interpet/classify neural data and as a source of discovery of the processes that result in cognition, perception, emotion and pathology.
Cohen is passionate about graduate and post-graduate education. As the creator and director of the UCLA/Semel NeuroImaging Training Program he has pushed his students to an integrative understanding of the role of imaging in neuroscience: The use of images as hypothesis tests, the relationship between blurring, convolution, statistical error and inference from images, and an understanding of the structures common to neuroimages regardless of imaging modality.
His current focus now includes inquiry into the broader problems of images, beyond neuroscience, to encompass astronomy and nanoscale imaging, aesthetics to statistics, dimensional compression and dimensional expansion.
Cohen holds appointments in the UCLA Departments of Psychiatry, Neurology, Radiology, Biomedical Engineering, Psychology and Biomedical Physics and is a member of the California NanoSystems Institute.
UCLA Semel Institute for Neuroscience and Human Behavior UCLA School of Medicine, Room C9-420 Los Angeles CA 90095
Ian Cook, MD
Ian A. Cook, M.D. holds the Joanne and George Miller and Family Endowed Chair in Depression Research. He is a Professor of Psychiatry and Biobehavioral Sciences in the David Geffen School of Medicine, and a Research Scientist at the Semel Institute for Neuroscience and Human Behavior. Dr. Cook received his bachelors degree with high honors from Princeton University and his medical degree from the Yale University School of Medicine. He completed his psychiatry residency training at UCLA’s Neuropsychiatric Institute, where he also was an NIMH-funded research fellow. Dr. Cook served on the Executive Committee on Practice Guidelines of the American Psychiatric Association, and guided the electronic dissemination of their evidence-based guidelines in psychiatry. A board-certified Psychiatrist, he has also served as an examiner for the American Board of Psychiatry and Neurology. His biography is profiled in Who’s Who in America, Who’s Who in the World, and Best Doctors. He is the author of numerous publications on brain function in mental illness and in aging, and holds several patents on biomedical devices and methods.
Semel Institute for Neuroscience and Human Behavior at UCLA 760 Westwood Plaza Los Angeles CA 90095
Bud Craig, PhD
Michelle G. Craske, PhD
Dr. Craske is Professor of Psychology, Psychiatry and Biobehavioral Sciences, and Director of the Anxiety Disorders Research Center, University of California, Los Angeles. She has published widely on the topics of fear and anxiety disorders, their etiology, assessment and treatment. She has been the recipient of continuous NIMH funding since 1993 for research projects pertaining to risk factors for phobias, anxiety disorders and depression; attentional biases and psychophysiological fear responding; the translation of basic science of fear extinction to human phobias and mechanisms of exposure therapy; and the development and implementation of treatments for anxiety and related disorders. Dr. Craske was Associate Editor for the Journal of Abnormal Psychology and is currently Associate Editor for Behaviour Research and Therapy is a Scientific Board Member for the Anxiety Disorders Association of America, and a member of the Anxiety Disorders Work Group for DSM-V.
Selected References:
Craske MG, Wolitzky-Taylor KB, Mineka S, Zinbarg R, Waters AM, Vrshek-Schallhorn S, Epstein A, Naliboff B, Ornitz E. Elevated responding to safe conditions as a specific risk factor for anxiety versus depressive disorders: Evidence from a longitudinal investigation. J Abnorm Psychol. 2011.
Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011 Jun;49(6-7):413-21. PubMed Central PMCID: PMC3100429.
Craske MG, Stein MB, Sullivan G, Sherbourne C, Bystritsky A, Rose RD, Lang AJ, Welch S, Campbell-Sills L, Golinelli D, Roy-Byrne P. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Arch Gen Psychiatry. 2011 Apr;68(4):378-88. PubMed Central PMCID: PMC3074172.
Craske MG, Kircanski K, Epstein A, Wittchen HU, Pine DS, Lewis-Fernández R, Hinton D; DSM V Anxiety; OC Spectrum; Posttraumatic and Dissociative Disorder Work Group. Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V. Depress Anxiety. 2010 Feb;27(2):93-112. Review.